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Introduction
In the pharmaceutical field, nanocarriers are designed to 
solve several limitations linked to the conventional forms of drug 
administration such the non-specific biodistribution of the drug, the 
lack of targeting towards specific cells or tissues, poor water solubility, 
low bioavailability, high toxicity and low therapeutic indices [1]. 
Particularly, polymeric nanoparticles (NPs) have been proposed both 
to stabilize and modulate the release of wide classes of drug (antibiotics, 
antitumorals, antifungines, vaccines etc) and, taking advantage of 
the formulative versatility of the carriers, to introduce new functions 
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Highlights 
Short collection of bullet points of the core article
1. Nanomedicine deserves interesting perspective for real 
application in medicine and surface modified nanocarriers represent 
the cutting-edge of nanomedicine.
2. Aiming to the maximum translatability, surface-modified nano-
carriers must be properly characterized, in terms of surface properties.
3. Advanced microscopies (Atomic Force Microscopy and 
Transmission Electron Microscopy) help in better understanding of 
the chemico-physical features of nanocarriers
4. AFM and TEM give high resolution outcomes and should be 
chosen depending on specific the nature of surface-ligands
5. AFM allows to discriminate on the qualitative evaluation of 
ligands of different nature (QDs vs antibody) , without any additional 
treatment and without operating in a vacuum environment 
Abstract
In the field of nanomedicine, the characterization of functionalized drug delivery systems, introduced on market as 
efficacious and selective therapeutics, represents a pivotal aspect of great importance. In particular, the morphology 
of polymeric nanoparticles, the most studied nanocarriers, is frequently assessed by transmission electron microscopy 
(TEM). Despite of TEM high resolution and versatility, this technology is frequently hampered by both the complicated 
procedure for sample preparation and the operative condition of analysis. Considering the scanning probe microscopies, 
atomic force microscopy (AFM) represents an extraordinary tool for the detailed characterization of submicron-size 
structure as the surface functionalization at the atomic scale. In this paper we discussed the advantage and limits of 
these microscopies applied to the characterization of PLGA nanoparticles functionalized with three different kinds of 
ligands (carbohydrate ligand, an antibody and quantum dots crystals) intentionally designed, created and tailored with 
specific physico-chemical properties to meet the needs of specific applications (targeting or imaging).
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quantum dots (QD) to obtain double imaging/drug release (theranostic 
aim). If compared with the encapsulation process, the conjugation and 
the exposure of QD on NPs surface is preferred in order to avoid the 
QD release and to ensure the optimal imaging [12,13].
Materials and Methods
Preparation of  nanoparticles
All NPs analysed were obtained according to the nanoprecipitation 
procedure [14]. The functionalization can be inserted during NPs 
formulation by using polymer previously modified (Neu5Ac-PLGA502) 
or after the NPs formation by activating the functional groups onto 
NPs surfaces by “in situ” reaction and subsequent conjugation with 
ligands (Rituximab-PLGA503 NP and QD-PLGA503 NPs).
Sialic acid derivative conjugated nanoparticles (Neu5Ac-
PLGA502 NPs)  : Initially, PLGA502H (50% lactic/50% glycolic acid 
ratio, inherent viscosity 0.20 dl/g, MW 4900; Boehringer-Ingelheim, 
Ingelheim am Rhein, Germany), selected as polymer on the basis of 
the yield of sugar conjugation, was conjugated with Neu5Ac (Sigma 
Aldrich), a sialic acid derivative, by applying the protocols previously 
reported [15,16]. Then, a mixture composed by Neu5Ac-PLGA502 (5 % 
w/w) and PLGA502H (95% w/w) was dissolved in acetone (8 mL). The 
organic phase was then added dropwise into deionised water (25 mL) 
containing poloxamer 188 (Pluronic F68®, 100 mg) (Sigma Aldrich). 
After stirring at r.t. for 10 min, the organic solvent was removed at 
30°C under reduced pressure (10 mmHg). The final volume of the 
suspension was adjusted to 10 mL with deionised water. The Neu5Ac-
PLGA502 NPs were then purified by gel-filtration chromatography 
(Sepharose CL 4B gel (160 mL), column 50×2 cm, Sigma Aldrich, 
Italy), using water as the mobile phase. Un-modified PLGA502H 
NPs, prepared with the same experimental conditions but using only 
un-modified PLGA502H as the polymer, were considered as control 
samples. At least 3 batches of each NP sample were prepared.
Antibody conjugated nanoparticles (Rituximab-PLGA503 NPs): 
Rituximab (anti-human CD20 Ab-Mabthera; Roche, Basel, Switzerland) 
engineered NPs were prepared starting from un-modified PLGA503H 
NPs (50% lactic/50% glycolic acid ratio, inherent viscosity 0.38 dl/g, 
MW 11000; Boehringer-Ingelheim, Ingelheim am Rhein, Germany) 
applying the methodology previously described [17,18]. Briefly 50 
mg of  PLGA 503H NPs were reacted with  150 mg of 1-Ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC; Sigma Aldrich, Saint Luis, 
MO) and 50 mg of N-Hydroxy-succinimide (NHS, Sigma Aldrich)  in 
0.1 M of 2-(N-morpholino) ethanesulfonic acid (MES, Sigma Aldrich) 
ethanesulfonic acid (MES, Sigma Aldrich) buffer (pH 4.7) and stirred 
at r.t. for 1 hour.  EDC and NHS are used to activate carboxylic acid 
groups at the PLGA’s nanoparticle surface, with formation of activated 
ester groups able to react with primary amino groups of the antibody. 
The activated NPs were collected by ultracentrifugation at 15, 000 rpm 
for 10 min at 4°C and the excess of reagents were removed. Activated 
NPs were re-suspended in PBS buffer pH 7.4 and stirred at r.t. for 1 
hour with the designated volume of Rituximab (100 µL of a 1 mg/mL 
stock solution) in order to obtain Rituximab-PLGA503 NPs. After the 
reaction, the suspension of these engineered NPs were collected by 
centrifugation and further washed twice by distilled water. At least 3 
batches of each NP sample were prepared.
QD conjugated nanoparticles (QD-PEG-PLGA503 NPs): 
PLGA503H NPs were previously obtained according to the 
nanoprecipitation technique by using as polymer PLGA503H and 
the 1% (w/v) of PVA acqueous solution as dispersing phase. The 
for targeting drugs and imaging agents [2,3]. In these contest, recent 
advances in the nanotechnology field are based on the functionalization 
of nanocarriers by incorporation, adsorption or conjugation of ligands 
(polymers, carbohydrates, antibodies, endogenous substances or 
markers) to their surface. The problems related to the characterization 
of nanocarriers and to the surface functionalization represent a major 
drawback to formulative developments. Moreover, the validity of 
some of the conclusions related to the quali-quantitative detection 
of the surface functionalization may be questionable although 
several analytical approaches have been proposed for characterizing 
the modified nanosystems, not leading to a standardized protocol 
and therefore comparable readouts. Nowadays, the most common 
techniques for the analysis of surface properties of functionalized 
nanocarriers are the zeta potential (ζ-pot) and the X-Ray analyses, 
particularly the Electron Spectroscopy for Chemical Analysis (ESCA). 
ζ-pot analysis is routinely used to define the surface charge of NPs 
and therefore the effects of the surface modification. Unfortunately, 
this approach does not allow to evaluate other  properties such as the 
density and the homogeneity of the modification. Moreover, ζ-pot is 
accurately measured if the formulation satisfy several criteria such as 
its monodispersivity, low salt concentrations (conductivity <1 mS/cm), 
and the use of a particulate free polar dispersant as, for example, high 
purity water [4].
Like ζ-pot, the analysis of the chemical composition of the NPs 
surface by ESCA is often indicative of the presence of coating [5] 
but this qualitative detection does not clarify both the atomic surface 
arrangement and the local micro-structured occurred after surface 
functionalization. Details on the morphology, shape, macro- and 
microstructure characteristics of the NPs surface can be obtained by 
using a microscopical approach. Particularly the transmission electron 
microscopy (TEM) and the scanning probe microscopy (atomic force 
microscopy, AFM) are widely used to characterize nano- and atomic 
scale materials. TEM imaging has significantly higher resolution than 
the other microscopic procedures such as the light-based imaging 
technique. The nature of the substances and the preparation methods 
of the samples are extremely important in order to obtain high-quality 
images having the greatest contrast between NPs (or the surface details) 
and background.
The high resolution is also the most appealing advantage of AFM 
respect to other techniques such as electron microscopies (for example 
TEM). AFM allows 3D visualization and qualitative and quantitative 
information on native samples in physiological like conditions [6,7], 
avoiding complex sample preparation procedures and thus the 
connected artifacts.
Also in these cases, criticism should be addressed to detail the NPs 
surface. As example, the amplitude of forces involved and then the 
imaging mode to be adopted for the analysis should be appropriately 
set up on the nature of the samples [8].
Starting from these basis, this paper aims to define the preparative 
procedures of sample and the applicability of TEM and AFM techniques 
towards the evaluation of the surface details with sub-nanometer 
resolution in NPs modified by different kinds of ligands. To reach this 
aim, we prepared and analysed poly-lactide-co-glicolide (PLGA) NPs 
functionalized on the surface with ligands having different chemical 
nature and composition and capable to provide to the NPs physical-
chemical properties required for specific application. We tested NPs 
engineered with a) a sialic acid derivative (Neu5Ac) direct against 
tumors (targeting aim) [9]; b) rituximab antibody recognized by 
B-chronic lymphocytic leukaemia cells (targeting aim) [10,11] and c) 
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PLGA503 NPs were incubated with nanogold (mono-sulfo-N-
Hydroxy-succinimido Nanogold®, Nanoprobes, Yaphank, NY, USA) 
(size 1.4 nm) able to react with Ab amine groups  in order to provide a 
qualitative identification of Ab. As the control, we performed the same 
coupling reaction using PLGA503H NPs without Ab on the surface. 
Following the procedures given by the manufacturer, a weighted 
amount (1 mg) of lyophilized PLGA503H NPs or Rituximab-PLGA503 
NPs were suspended in phosphate buffer (pH 7.8), added to 300 uL of 
a nanogold suspension (9 nmol) and adjusted to a final volume of 3 mL 
of solution. After purification, the NPs coupled with nanogold were 
placed on a copper grid coated with thin layer of carbon and processed 
for TEM analysis.  
QD-PEG-PLGA503 NPs was observed without any treatment. 
The particle suspension was deposited on a copper grid  and analysed. 
Elemental analysis of samples was also performed using TEM-Energy 
Dispersive X-ray Spectroscopy (EDS, Energy TEM INCA 300, Oxford 
Instruments, Halifax Road, Buckinghamshire HP12 35E, UK). In 
particular, in order to verify the presence of QDs on NPs, an arbitrarily 
chosen representative area of the sample was hit by primary beam 
electrons of TEM thus to produce X-rays that carry information as 
to the type of atoms (the elements) in the sample. Information about 
elemental composition and elemental weight % were displayed as a 
spectrum, identifying the present elements, by means of Oxford INCA 
100 software.
Atomic force microscopy (AFM): Atomic force microscopy 
(AFM) was used to better clarify the morphology and the surface 
structure of the samples. The atomic force microscopical observations 
were performed with an Atomic Force Microscope (Park Instruments, 
Sunnyvale, CA, USA) at about 20°C operating in air and in Non-
Contact (NC) mode using a commercial silicon tip-cantilever (high 
resolution noncontact “GOLDEN” Silicon Cantilevers NSG-11, NT-
MDT, tip diameter=5–10 nm; Zelenograd, Moscow, Russia) with 
stiffness about 40 Nm−1 and a resonance frequency around 170 kHz. 
After the purification, the sample dispersed in distilled water were 
applied on a freshly cleaved mica disk (1 cm×1 cm); 2 min after the 
deposition, the water excess was removed using blotting paper. The 
AFM images were obtained with a scan rate 1 Hz and processed using a 
ProScan Data Acquisition software. Two kinds of images are obtained: 
the first one is a topographical image and the second one is indicated as 
“error signal”. This error signal is obtained by comparing two signals: 
the first one, direct, representing the amplitude of the vibrations of the 
cantilever, and the other one being the amplitude of a reference point. 
The images obtained by this method show small superficial variations 
of the samples. Images were flattened using second-order fitting to 
remove [sample tilt] background curvature and slope from the images.
Results
Neu5Ac-PLGA502 NPs vs non functionalized PLGA502H 
NPs
The hydrodynamic diameters (Z-average) of the non-engineered 
PLGA502H NPs measured by PCS are around 170 nm and the size 
distributions are relatively narrow (polydispersity<0.1) Table 1. These 
NPs exhibit high negative value of ζ-pot (within -30 mV) owing to 
the exposure of carboxylic group of PLGA that indicates high electric 
charge on the surface of the NPs, which is responsible for the strong 
repulsive forces amongst the particles that prevents their aggregation 
in water and favors formation of stabilized NPs. The functionalization 
with Neu5Ac do not alter significantly the ζ-pot value of NPs.
NPs surface was activated via NHS/EDC as previously described for 
Rituximab-PLGA503 NPs (section 2.1.2.). The activated NPs were re-
suspended in 4.5 mL of PBS pH 7.4. Then, 3 mL (corresponding to 
about 30 mg of NPs) of the NPs suspension were conjugated with 100 
pmol of QD-PEG-NH2 (Qdot605 ITK, Life technologies, Monza, Italy) 
to obtain QD-PEG-PLGA503 NPs. The reaction was allowed to carry 
out for 1 h at r.t.. Free QDs-PEG-NH2 were removed by centrifugation 
and collected QD-PEG-PLGA503 NPs were re-suspended in deionized 
water. At least 3 batches of each NP sample were prepared.
Physico-chemical characterization of NPs
Photon correlation spectroscopy (PCS): All NPs were analyzed in 
distilled water for particle size (Z-average), polydispersivity index (PDI) 
and zeta potential (z-pot) by photon correlation spectroscopy (PCS) 
and laser Doppler anemometry using a Zetasizer Nano ZS (Malvern, 
UK; Laser 4 mW He–Ne, 633 nm, Laser attenuator Automatic, 
transmission 100% to 0.0003%, Detector Avalanche photodiode, Q.E 
>50% at 633 nm, t=25°C). The results were normalized with respect to 
a polystyrene standard solution. All the data are expressed as means of 
at least three determinations carried out for each preparation lot (three 
lots for each sample).   
X-ray photoelectron spectroscopy (ESCA analysis): ESCA 
(Electron Spectroscopy for Chemical Analysis) is a surface-sensitive 
technique that measures the elemental composition and identifies the 
chemical functional groups in the 10 nm-thick surface layer of the 
sample. The composition of the surface layer of the Neu5Ac-PLGA502 
NPs was determined from the detailed analysis of the C1s peak 
collected with a XRC 1000 X-ray source analysis system (Specs Surface 
Nano Analysis, Germany) and a Phoibos 150 hemispherical electron 
analyzer (Specs Surface Nano Analysis, Germany), using MgKα1,2 
radiations. The spectra were recorded in FAT (fixed retardation ratio) 
mode with 190 eV pass energy. The pressure in the sample analysis 
chamber was about 10−10 Torr. Data acquisition was performed with 
the RBD AugerScan 2. High-resolution data were collected using a pass 
energy of 50 eV in 0.1 eV steps. Curve-fitting routines were performed 
with Igor Pro software. Signals were attributed as reported by Bondioli 
and coworkers (15).
ESCA was used also to quantify the presence of nitrogen atoms on 
the surface of Rituximab-PLGA503 NPs. 
Transmission electron microscopy (TEM): A negative staining 
procedure was applied to observe the structure of both PLGA-502H 
NPs and Neu5Ac-PLGA502 NPs with TEM operating at an acceleration 
voltage of 200 KV (model JEM 2010; JEOL, Peabody, MA). To prepare 
particles for negative staining, a drop of a water-diluted suspension of 
the samples (about 0.05 mg/mL) was placed on a copper grid that was 
coated with a thin layer of carbon (TABB Laboratories Equipment, 
Berks, UK), allowed to adsorb and the surplus was removed by filter 
paper. Then, a drop of 2% (w/v) aqueous solution of uranyl acetate 
was applied to the sample for 5 min, and then wicked away; the 
concentration of uranyl acetate applied in this study was the most 
suitable to maintain the integrity of the sample during the preparation 
[19]. The sample was dried at room conditions before the NPs were 
imaged with a TEM.
Materials with electron densities that are significantly higher than 
amorphous carbon are easily imaged. These materials include most 
metals (e.g., silver, gold, copper, aluminum) and most oxides (e.g., 
silica, aluminum oxide, titanium oxide). Thus, in order to further 
assess the presence of Rituximab on the NPs surface, the Rituximab-
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show in fact a mean diameter larger than 200 nm, with a broader size 
distribution (PDI>0.2). 
Table 2: PLGA503H NPs showed a negative ζ-pot value close to 
-25 mV; this value was due to the  presence of free carboxyl groups of 
the polymer PLGA partially masked by residual PVA, still present also 
after purification being adsorbed on the surface of the NPs (estimated 
in a percentage of 5%). This hypothesis is supported by some previous 
studies showing that PLGA503H NPs prepared without PVA have a 
ζ-pot value of about -60 mV, while in the presence of PVA, the potential 
becomes less negative reaching values close to neutrality [20].
In the NPs engineered with the antibody, the ζ-pot values remained 
closed to -20 mV, but distributed in a wide range of values, confirming 
the presence of a more complex surface if compared with that of 
PLGA503H NPs. 
Moreover, ESCA analysis, by investigating the presence of atoms 
(N) on the surface of Rituximab engineered NPs (Rituximab-PLGA503 
NPs) could give proof of success of the surface engineering procedure 
Table 2. In fact, the atomic spectra of the engineered NPs (Rituximab-
PLGA503 NPs) in comparison with that of non-engineered NPs 
(PLGA503H NPs) showed N signal indicating that the dislocation of 
Ab is on the NPs surface. The data indicated that the surface available 
for the interaction with the specific antigen can be approximately 
estimate to be about 7 ± 1% (percentage of derivatization).
TEM and AFM images of PLGA503H NPs described the defined 
and reproducible spherical morphology and smooth surface already 
observed for PLGA502H NPs (data not shown). Several differences 
were observed analyzing by TEM and AFM the Rituximab-PLGA503H 
NPs. To evaluate the presence of Ab on the NPs surface and in order 
to assess its reactivity, we set up a reaction of the Ab with gold NPs 
(Nanogold®) that appear well contrasted in the TEM microphotographs 
Figure 2. The images describe an heterogeneous population of NPs 
frequently connected by unformed material, probably due to residual 
reaction reagents not completely removed by the purification process, 
altering the NPs contours. Moreover the magnifications of TEM 
micrograph Figures 2, clearly shows the presence of nanosized objects 
(arrows) with a diameter close to 5 nm scattered on particle surface. This 
small, denser and darker objects on the NPs surface were reasonably 
ascribable to heavy elements [21,22]. The black spots, analyzed by EDS, 
used for elemental composition analysis, were described to be Au based 
ESCA analysis was used to identify the chemical composition of the 
NPs and try to investigate the effective presence of the sialic acid layer. 
C1s signal of the ESCA spectrum of the non-engineered PLGA502H 
NPs can be deconvoluted into three components see Table 1. Neu5Ac-
PLGA502 NPs are characterized by an increase in the signal attributed 
to COO- with respect to the non-engineered PLGA502H NPs. The 
increase of this signal could be due to the greater hydrophilicity of the 
Neu5Ac moiety respect to that of the carboxylic end of the polymer. 
This characteristic allows the placement of the sialic residue on the NPs 
surface during their preparation by nanoprecipitation.
Table 1: AFM and TEM images of PLGA502H NPs and Neu5Ac-
PLGA502 NPs are shown in Figure 1. The images from negative-
staining TEM and NC-AFM of NPs prepared using PLGA502H, 
revealed a population of homogeneous particles with a regular surface 
Figure 1, panel a. The size of particles obtained ranged from 100 to 
200 nm. The range were consistent with the size obtained by PCS. At 
the same manner, the microscopical analysis of Neu5Ac-PLGA502 
NPs demonstrated the formation of spherical particles, with delimited 
contour and reproducible Z-average around 150 nm with a slightly 
increase of heterogeneity Figure 1, panel b. 
Figure 1: TEM image contrast provided information on the 
structure of both PLGA502H NPs and Neu5Ac-PLGA502 NPs. Both 
systems can be considered as amorphous structures and then, the 
bright/dark contrast observed in TEM images can be ascribed to 
the Z number of atoms of components and to the thickness of the 
samples. Unfortunately, the same atoms (C, O, H) formed compositive 
polymer (PLGA502H) and sialic acid residue (Neu5Ac). Therefore, 
it is impossible to discriminate between the polymeric NPs and their 
surrounding layer. In fact, TEM microphotographs of Neu5Ac-
PLGA502 NPs are similar as those of PLGA502H NPs. Also AFM 
experiments were unable to show the changes in surface topography of 
Neu5Ac-PLGA502 NPs respect to that of PLGA502HNPs.
Rituximab-PLGA503 NPs vs non functionalized PLGA503H 
NPs
A monomodal and monodisperse (PDI<0.1) distribution describes 
the PLGA503H NPs sample Table 2. The average hydrodynamic 
diameter (Z-average obtained by PCS analysis) of the NPs is ranged 
between 150 and 170 nm. The range is lower than that of engineered 
NPs on the surface with the Ab (Rituximab); Rituximab-PLGA503 NPs 
PCSa ESCAb
4 4
CH3 CH3
2 2
3
+
3
n
3
3
1 O
O
OO
O
O
O
O O
PLGA502Hc              Surfactant (Pluronic)c
Sample Sized (nm) PDId,e z-pot (mV)d COO (1)
f 
290.5 eV
COO–C–O (2)f 
288.5 eV
C–CH (3)f 
(overlapped to (4)f) 
286.5 eV
PLGA502H NPs 171 (11) 0.09 (0.01) −31 (2) 30.8 35.9 33.3
N e u 5 A c - P L G A 5 0 2 
NPs 163 (5) 0.20 (0.02) −37 (4) 36.0 35.4 28.6
aPCS: Photon Correlation Spectroscopy analyses
bESCA: Electron Spectroscopy for Chemical Analysis 
cAtomic composition and numbering of the components of PLGA502H NPs, PLGA and Pluronic. 
dThe values represent the means of at least three experiments; standard deviation in parentheses. 
ePDI: polydispersity index.
f The numbers indicate the carbon atom type
Table 1: Chemico-physical characterization and ESCA analysis of PLGA502H NPs and Neu5Ac-PLGA502 NPs
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and therefore to be due to Nanogold® labelling and confirming the Ab 
molecules conjugated on the NPs surface Table 2. 
Figure 2: By using NC-AFM, surface alterations after conjugation 
with Rituximab appeared evident, without any preliminary preparative 
treatment of the samples. Structurally, Ab engineered NPs (Rituximab-
PLGA503 NPs) were characterized by larger aggregates having 
irregular shapes. The analysis of the topographical images of the 
samples Figure 2 showed that, in accordance with the size measured 
by PCS analysis, the diameters of Rituximab-PLGA503 NPs were in a 
wide range (100-300 nm). The NPs were characterized by an irregular 
shape and fragmented contours. Additionally, the surface appeared 
characterized by the presence of grains not isolated any more, as 
already observed for similar systems [23,24]. The “Error signal” 
image and 3D reconstruction Figures 2 well detailed the surface of 
NPs where spherical structures with diameters of about 8–10 nm are 
present. This structure could be recognized as Ab molecules, as the 
images strongly agree with AFM images showing trimeric structures 
with comparable size of IgG [25]. Based on these results, AFM imaging 
appears particularly attractive to characterize particulate matter based 
on organic materials with high spatial resolution, such as Ab anchored 
on NPs surface, without any concern about scattering cross sections 
and sample treatment procedures.
QD-PEG-PLGA503 NPs vs non functionalized PLGA503H 
NPs
The QD-PEG-NH2 used in this experiment are featured by a 
CdSe core encapsulated in a crystalline shell of ZnS and an external 
amphiphilic polymer coating to prevent formation of free Cd. The 
average particle size of CdSe/CdZnS QDs is approximately 26±1 
nm as measured by PCS, probably due to aggregation phenomena. 
PCS analysis of QD-PEG-PLGA503 NPs were reported in Table 3. If 
compared with PLGA503H NPs, the Z-average of engineered QD-
PEG-PLGA503 NPs slightly increased from 160 ± 10 to 179 ± 13 
nm. As the non-engineered NPs, QD-PEG-PLGA503-NPs appeared 
monomodal and uniformely distributed (0.09< PDI<0.13). 
Table 3: The values of the ζ-pot appeared affected by the presence 
on the surface of QD-PEG-NH2 chains. An increase in the surface 
charge for QD–PEG-PLGA503 NPs was occurred (−17 ± 2 mV) if 
compared with that of non-engineered PLGA503H NPs (−25 ± 2 mV). 
This difference in the ζ-pot is justified by literature data describing the 
ability of PEG polymer to mask the PLGA NPs surface, and particularly 
the exposed carboxyl group [26, 27].
Figure 3: We first observed QD-PEG-NH2 by using TEM; based 
on contrasted images, we recognized  and measured the size of the 
QD’s core-shell (CdSe/ZnS) that was found around 7-8 nm Figure 3; to 
evaluate the entire QD-PEG-NH2 we applied the AFM analysis Figure 
3. By using this approach, we recognized the spherical formation of 
QDs with a diameter ranging approximately from 20 nm to 25 nm 
Figure 3. These observations were in agreement with previous papers 
[28-30].
To visualize how the surface of PLGA503H NPs is engineered with 
QDs, we analyzed the images captured by TEM Figure 4. Some of the 
NPs were still QD-free (data not shown), but in most of the evaluated 
cases some QDs were located on peripheral of NPs. QDs were scattered 
along the surface, confined in well located area with the tendency of 
the aggregation.
Energy Dispersive X-Ray using the EDS detector was used to map 
the QD-PEG-NH2 based on their composition 
Figure 4: PEG is composed mostly of carbon and oxygen, the 
same composition of PLGA polymer. PEG surrounding of Cd/Se core 
was not mapped. Unfortunately, the carbon signal with respect to the 
other signals was significantly larger diminishing the resolution of the 
smaller cadmium and selenium peaks, that appeared with a percentage 
close to 0.4% and <0.1%, respectively.
QD-PEG-PLGA503 NPs were easily visualized and characterized 
through AFM scanning, once the suspension was deposed on a mica 
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Figure 1: Microscopical analysis of PLGA502H NPs (Panel A) and Neu5Ac-
PLGA502 NPs (Panel B). TEM microphotographs; “Height’’ image  and “3D 
reconstruction” from AFM.
PCSa ESCAb
Samples Sizec (nm) PDIc,d z-pot (mV)c O (%) C (%) N (%) Deriv.(%)
PLGA503H NPs 160 (10) 0.05 (0.01) -25 (2) 37.8 (0.8) 63.2 (0.9)
Rituximab-PLGA503- 
NPs 223 (25)
0.21
(0.03) -20 (7)
35.2
(0.5) 62 (0.7) 1.4 (0.2)
7 
(1)
aPCS: Photon Correlation Spectroscopy analysis
bESCA: Electron Spectroscopy for Chemical Analysis 
cThe values represent the means of at least three experiments; standard deviation in parentheses. 
dPDI: polydispersity index.
Table 2: Chemico-physical characterization and ESCA analysis of PLGA503H NPs and Rituximab-PLGA503NPs
PCS a EDSb
Sample Sizec (nm) PDIc, d z-pot (mV)c Cd vs C (%)
PLGA503H NPs 160 (10) 0.05 (0.01) -25  (2)
QD-PEG-NH2 26 (1) 0.29 (0.01) -21 (4)
QD-PEG-PLGA503 NPs 179 (13) 0.11 (0.02) -17 (2) 0.4(0.02)
aPCS: Photon Correlation Spectroscopy analyses
bEDS: Energy dispersive X-ray Spectroscopy
cThe values represent the means of at least three experiments; ±: standard 
deviation in parentheses. 
dPDI: polydispersity index.
Table 3: Chemico-physical characterization and EDS analysis of PLGA503H NPs, 
QD-PEG-NH2 and QD-PEG-PLGA503 NPs
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support. AFM topography images of QD-PEG-PLGA503 NPs sample 
deposited on mica demonstrate the presence of spherical flattened 
particles, quite polydisperse with a mean diameter of about 230 
nm Figure 4. Interestingly, the height AFM image showed that the 
conjugation of QD with NPs does not result in a regular surface, but 
rather in a discontinuous rough one. This was in sharp contrast with 
the control NPs showing a smooth surface. Also 3D image analysis 
indicated that QD were randomly distributed the surface of NPs, 
forming visible agglomerates Figure 4. Moreover, the adsorption/
conjugation of QD-PEG-NH2 molecules on the NPs surface, reducing 
the net charge as demonstrated also by ζ-pot analysis, could promote 
the formation of aggregates and flattened species among the NPs. 
The occurrence of these destabilization might be strongly reduced in 
suspension samples for the presence of solvatation interactions, but 
they are predominant in solid state and therefore they can strongly 
affect the chemical-physical behavior of the samples. As evident, AFM 
is one of the few methods which allows one to visualize the formation 
of these assemblies.
Conclusions
This study demonstrates that AFM and TEM are really representing 
good options to be able to discriminate amongst the ligands conjugated 
on the NP surface. These technologies would be really useful especially 
in the view of the upcoming era of surface engineered nanomedicines. 
In fact, there is need for a precise, clear and accurate characterization 
of active surface of these new smart carriers.
Advance surface-analysis technologies should be chosen in function 
of the ligands/molecules used for surface engineered of nanomedicines.
In this view, in this paper, we showed that TEM and AFM can work 
together, giving at the same time different information of different 
nature, converging to draw a more and precise “picture” of the novel 
nanomedicine.
Without any staining or macromolecules labeling (like metallic 
nanogold) the TEM detection of organic molecules using as ligand 
(such as carbohydrate or antibody)composed by the same element 
of the matricial structure of nanoparticles, is difficult. In particular, 
we showed that despite the high resolution of the two microscopical 
techniques, low molecular weight molecules, such as sugar residues 
(Neu5Ac), anchored to the surface of polymeric NPs were not 
detectable both with TEM and AFM.
 QD, that are materials with electron densities significantly higher 
than amorphous carbon are easily imaged by using TEM, but also 
detectable by AFM approach without any additional treatment of the 
samples and without operating in a vacuum environment.
As support of our conclusion, we detected by TEM the presence of 
antibody, a complex high molecular weight ligand, on nanoparticles 
surface only by introducing Nanogold® labeling. Also in this case, 
AFM allowed to discriminate on the qualitative evaluation of antibody, 
without any preparative treatment of the sample.
 Moreover, AFM images shows 3D-data allowing the height of 
the observed object to be measured as well as the heterogeneity/
discontinuity of the coverage or the surface alteration occurred during 
the functionalization of  NPs to be defined. Hence, AFM can support 
additional analytical techniques allowing the sample characterization 
as detailed as possible.
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Figure 2: Microscopical analysis of Rituximab-PLGA503 NPs. Microphotograph 
and magnifications from TEM; “Height’’ image, “Error signal” image and 3D 
reconstruction from AFM.
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Figure 4: Microscopical analysis of QD-PLGA503 NPs. Microphotograph, 
magnification, and EDS analysis from TEM; “Height”, “Error signal” and 3D 
reconstruction from AFM.
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